Manulife (Manufacturers Life Insurance)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,068
| Closed | -$1.64M | – | 3026 |
|
|
2023
Q2 | $1.64M | Sell |
16,068
-4,343
| -21% | -$443K | ﹤0.01% | 1472 |
|
|
2023
Q1 | $1.86M | Buy |
20,411
+9,532
| +88% | +$867K | ﹤0.01% | 1422 |
|
|
2022
Q4 | $413K | Sell |
10,879
-262
| -2% | -$9.95K | ﹤0.01% | 2111 |
|
|
2022
Q3 | $280K | Sell |
11,141
-77
| -0.7% | -$1.94K | ﹤0.01% | 2346 |
|
|
2022
Q2 | $341K | Sell |
11,218
-218
| -2% | -$6.63K | ﹤0.01% | 2305 |
|
|
2022
Q1 | $375K | Sell |
11,436
-2,781
| -20% | -$91.1K | ﹤0.01% | 2367 |
|
|
2021
Q4 | $375 | Buy |
14,217
+39
| +0.3% | +$1 | ﹤0.01% | 2461 |
|
|
2021
Q3 | $1.43M | Sell |
14,178
-1,320
| -9% | -$133K | ﹤0.01% | 1631 |
|
|
2021
Q2 | $2.19M | Buy |
+15,498
| New | +$2.19M | ﹤0.01% | 1572 |
|
|
2020
Q2 | – | Sell |
-14,461
| Closed | -$2.09M | – | 2959 |
|
|
2020
Q1 | $2.09M | Buy |
14,461
+1,620
| +13% | +$234K | ﹤0.01% | 1293 |
|
|
2019
Q4 | $2.63M | Buy |
12,841
+124
| +1% | +$25.3K | ﹤0.01% | 1341 |
|
|
2019
Q3 | $1.07M | Sell |
12,717
-52
| -0.4% | -$4.38K | ﹤0.01% | 1613 |
|
|
2019
Q2 | $1.21M | Buy |
12,769
+178
| +1% | +$16.8K | ﹤0.01% | 1558 |
|
|
2019
Q1 | $1.08M | Buy |
12,591
+1,155
| +10% | +$98.7K | ﹤0.01% | 1648 |
|
|
2018
Q4 | $641K | Sell |
11,436
-985
| -8% | -$55.2K | ﹤0.01% | 1829 |
|
|
2018
Q3 | $1.02M | Buy |
12,421
+89
| +0.7% | +$7.28K | ﹤0.01% | 1793 |
|
|
2018
Q2 | $431K | Buy |
12,332
+3,207
| +35% | +$112K | ﹤0.01% | 2505 |
|
|
2018
Q1 | $187K | Sell |
9,125
-411
| -4% | -$8.42K | ﹤0.01% | 3072 |
|
|
2017
Q4 | $270K | Buy |
9,536
+484
| +5% | +$13.7K | ﹤0.01% | 2789 |
|
|
2017
Q3 | $282K | Buy |
9,052
+1,709
| +23% | +$53.2K | ﹤0.01% | 2706 |
|
|
2017
Q2 | $233K | Buy |
7,343
+3,715
| +102% | +$118K | ﹤0.01% | 2886 |
|
|
2017
Q1 | $82K | Buy |
3,628
+1,871
| +106% | +$42.3K | ﹤0.01% | 3249 |
|
|
2016
Q4 | $38K | Buy |
1,757
+1,208
| +220% | +$26.1K | ﹤0.01% | 3482 |
|
|
2016
Q3 | $14K | Buy |
+549
| New | +$14K | ﹤0.01% | 3628 |
|